IBEX's Record Free Cash Flow Makes Its AI-Threat Discount Harder to Defend

The cleanest way to describe the case against IBEX Limited is also the way most retail investors already think of it: it runs call centers, so artificial intelligence should eventually put it out of business. That fear has been the lens for a long time. Then the company went and closed a fiscal year that makes the lens harder to keep clean.

IBEX (Nasdaq: IBEX) outsources customer-experience and back-office work for large brands, the category most exposed to the AI-replaces-agents narrative. For the fiscal year ended June 30, 2026, it reported record revenue of $644.1 million, up 15.4%, its sixth straight quarter of double-digit growth. Revenue was up across its biggest verticals — HealthTech grew 38.5%, Technology 25.6%. Pick the growth line apart and the repeated theme is that the business got stronger, not weaker, over the twelve months the market spent worrying.

What carries the argument for me is not the revenue, though. It is the cash. IBEX produced a record $59.0 million of operating cash flow and record free cash flow of $31.2 million, up from $27.3 million a year earlier, and ended the year with a net cash position of $30.9 million after being at $13.7 million a year before. A company that is supposedly a sinking ship does not normally sit on net cash and keep printing more of it.

The market is still pricing the old story

The reason this matters is the gap between that cash path and how the stock is still being received. The aggregate rating signal from AInvest labels the stock a Hold, with a fundamental score that is far below its liquidity score — the kind of profile you get when the broad market is neutral-to-skeptical rather than persuaded. Even after a roughly 30% run over the last four months, the shares sit near their one-year high at about $37, and the forward earnings multiple is well below the double-digit growth the company is guiding to.

That combination — improving numbers underneath, a skeptical aggregate stance on top — is the classic setup where the market is still pricing the old risk profile while the operating setup is already getting cleaner. It is not excitement. It is a business that becomes harder to dismiss the longer the free cash flow keeps showing up.

To put a price on it without pretending to precision: on the midpoint of fiscal 2027 guidance, enterprise value of roughly $485 million against around $92 million of projected adjusted EBITDA leaves the stock at about five times forward EBITDA. Net cash is nearly all of that gap compared to market cap, so the operating multiple is genuinely low for a business still growing.

The honest friction

I do not want to oversell the setup, because there is real friction in the current quarter. Fourth-quarter net income actually fell to $8.7 million from $9.6 million a year earlier even as revenue grew 11.6%, because IBEX was paying training costs for new clients and shifting work from nearshore to offshore delivery centers. Management calls these temporary. They probably are — but the margin dip is exactly the kind of thing that, if it drags on, would keep the stock cheap for a reason.

There is a second and bigger uncertainty. The entire bullish version of this story rests on AI becoming an opportunity rather than the threat — IBEX has a partnership with Sierra, more than ten AI-agent implementations across five verticals, and two strategic AI-agent wins in the fourth quarter. But management has not quantified what those produce. That is a genuine hole: the AI thesis is real conceptually and unproven in the numbers. When the proof is fuzzy, I fall back on the thing that is not fuzzy — the cash flow.

The fiscal 2027 guidance helps lay out the next twelve months. IBEX guided revenue to $700–715 million, growth of 9–11%, with adjusted EBITDA of $90–94 million, up 9–14%, and lighter capital spending of $25–30 million. Growth decelerates from the 15.4% printed this year, which is honest. But the lower capex matters more to someone who reads the cash flow first: if operating cash keeps rising while spending eases, free cash flow has room to climb from the record it just set.

What would change the picture

The concrete condition that makes this work — and the one that would break it — is the same number. IBEX's case is only as strong as its ability to keep converting growth into free cash flow while margins recover from the current-quarter dip. If fiscal 2027 delivers another record in free cash flow, the "AI kills the call-center outsourcer" discount becomes progressively harder to defend at five times forward EBITDA. If margins keep sliding instead, or the AI projects start eating cash without producing it, then the low multiple is not a bargain; it is the market correctly pricing a grind-down.

I can be wrong again, and this is not a name where I would reach for a fixed target or a precise timeline. But the direction of the evidence favors the operating path, and the cash flow is the part I can actually check. IBEX has the makings of a reset where expectations are still muted while the money flows in. Whether that translates into a rerating comes down to one line on the cash-flow statement a year from now.